Route of primary HTLV-1 infection regulates HTLV-1 distribution in reservoir organs of infected mice

被引:4
作者
Tanaka, Masakazu [1 ,2 ,3 ]
Nitta, Takayuki [1 ,2 ]
Sun, Binlian [2 ]
Fujisawa, Jun-Ichi [3 ]
Miwa, Masanao [1 ,2 ]
机构
[1] Nagahama Inst Biosci & Technol, Grad Sch Biosci, Dept Genet & Cell Biol, Shiga 5260829, Japan
[2] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan
[3] Kansai Med Univ, Dept Microbiol, Osaka 5708506, Japan
基金
日本学术振兴会;
关键词
human T-cell leukemia virus type-1; mouse model; route of infection; T-CELL LEUKEMIA; VIRUS TYPE-I; TYPE-1; BLOOD; SYSTEM; TRANSFORMATION; TRANSMISSION; INHIBITOR; EXPANSION; CARRIERS;
D O I
10.3892/etm.2010.179
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Human T-cell leukemia virus type-1 (HTLV-1) causes adult T-cell leukemia and HTLV-1-associated myelo-pathy/tropical spastic paraparesis. HTLV-1 is mainly transmitted through blood transfusion and breastfeeding, but viral proliferation in the body in vivo shortly after transmission is not well understood. To investigate whether the route of infection influences the early stages of viral proliferation, we inoculated BALB/c mice with MT-2 cells, an HTLV-1-producing human T-cell line, via different routes, and evaluated the proviral load and humoral immune responses. One month after infection, the provirus was detected in most organs of the mice infected intraperitoneally, and substantial proviral loads were detected in the peripheral blood and secondary lymphoid organs. In contrast, the mice infected intravenously and orally showed low proviral loads, and the provirus distribution was limited to the spinal cord among the intravenously inoculated mice and to the liver among the perorally inoculated mice. Mice infected intraperitoneally also exhibited higher interleukin-2 production than the mice infected intravenously or orally, or than the uninfected control mice, while anti-HTLV-1 antibody titers were comparable between the mice infected intraperitoneally and intravenously. These results demonstrate that the route of primary HTLV-1 infection influences the establishment of HTLV-1-infected cell proliferation and the cell reservoir in mice.
引用
收藏
页码:89 / 93
页数:5
相关论文
共 30 条
[1]   Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID/γcnull mice:: Suppression by an inhibitor against NF-κB [J].
Dewan, MZ ;
Terashima, K ;
Taruishi, M ;
Hasegawa, H ;
Ito, M ;
Tanaka, Y ;
Mori, N ;
Sata, T ;
Koyanagi, Y ;
Maeda, M ;
Kubuki, Y ;
Okayama, A ;
Fujii, M ;
Yamamoto, N .
JOURNAL OF VIROLOGY, 2003, 77 (09) :5286-5294
[2]   Transmission of human T-cell leukemia virus type 1 to mice [J].
Fang, JH ;
Kushida, S ;
Feng, RQ ;
Tanaka, M ;
Kawamura, T ;
Abe, H ;
Maeda, N ;
Onobori, M ;
Hori, M ;
Uchida, K ;
Miwa, M .
JOURNAL OF VIROLOGY, 1998, 72 (05) :3952-3957
[3]   Human T cell leukemia virus type I and neurologic disease: Events in bone marrow, peripheral blood, and central nervous system during normal immune surveillance and neuroinflammation [J].
Grant, C ;
Barmak, K ;
Alefantis, T ;
Yao, J ;
Jacobson, S ;
Wigdahl, B .
JOURNAL OF CELLULAR PHYSIOLOGY, 2002, 190 (02) :133-159
[4]   Expansion of human T-cell leukemia virus type 1 (HTLV-1) reservoir in orally infected rats: Inverse correlation with HTLV-1-specific cellular immune response [J].
Hasegawa, A ;
Ohashi, T ;
Hanabuchi, S ;
Kato, H ;
Takemura, F ;
Masuda, T ;
Kannagi, M .
JOURNAL OF VIROLOGY, 2003, 77 (05) :2956-2963
[5]   Risk factors for adult T-cell leukemia among carriers of human T-lymphotropic virus type I [J].
Hisada, M ;
Okayama, A ;
Shioiri, S ;
Spiegelman, DL ;
Stuver, SO ;
Mueller, NE .
BLOOD, 1998, 92 (10) :3557-3561
[6]   TUMORIGENICITY OF HUMAN T-CELL LEUKEMIA-VIRUS TYPE I-INFECTED CELL-LINES IN SEVERE COMBINED IMMUNODEFICIENT MICE AND CHARACTERIZATION OF THE CELLS PROLIFERATING IN-VIVO [J].
IMADA, K ;
TAKAORIKONDO, A ;
AKAGI, T ;
SHIMOTOHNO, K ;
SUGAMURA, K ;
HATTORI, T ;
YAMABE, H ;
OKUMA, M ;
UCHIYAMA, T .
BLOOD, 1995, 86 (06) :2350-2357
[7]   SUCCESSFUL GRAFT OF HTLV-I-TRANSFORMED HUMAN T-CELLS (MT-2) IN SEVERE COMBINED IMMUNODEFICIENCY MICE TREATED WITH ANTI-ASIALO GM-1 ANTIBODY [J].
ISHIHARA, S ;
TACHIBANA, N ;
OKAYAMA, A ;
MURAI, K ;
TSUDA, K ;
MUELLER, N .
JAPANESE JOURNAL OF CANCER RESEARCH, 1992, 83 (04) :320-323
[8]   Induction of human T cell leukemia virus type I receptors on quiescent naive T lymphocytes by TGF-β1,2 [J].
Jones, KS ;
Akel, S ;
Petrow-Sadowski, C ;
Huang, Y ;
Bertolette, DC ;
Ruscetti, FW .
JOURNAL OF IMMUNOLOGY, 2005, 174 (07) :4262-4270
[9]   Subversion of the innate immune system by a retrovirus [J].
Jude, BA ;
Pobezinskaya, Y ;
Bishop, J ;
Parke, S ;
Medzhitov, RM ;
Chervonsky, AV ;
Golovkina, TV .
NATURE IMMUNOLOGY, 2003, 4 (06) :573-578
[10]   Oral administration of human T-cell leukemia virus type 1 induces immune unresponsiveness with persistent infection in adult rats [J].
Kato, H ;
Koya, Y ;
Ohashi, T ;
Hanabuchi, S ;
Takemura, F ;
Fujii, M ;
Tsujimoto, H ;
Hasegawa, A ;
Kannagi, M .
JOURNAL OF VIROLOGY, 1998, 72 (09) :7289-7293